Home
FDA Expanded Access
FDA Expanded Access

NRx Expands Ketamine Access for Suicidal Depression via FDA Program
Imagine a world where hope reaches those in deepest despair. NRx Pharmaceuticals is making strides with an investigational ketamine therapy for suicidal depression, now more accessible through…